| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |